Xponance Inc. Sells 1,672 Shares of Cardinal Health, Inc. (NYSE:CAH)

Xponance Inc. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 2.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 58,043 shares of the company’s stock after selling 1,672 shares during the period. Xponance Inc.’s holdings in Cardinal Health were worth $5,851,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Federated Hermes Inc. grew its stake in shares of Cardinal Health by 5.8% in the fourth quarter. Federated Hermes Inc. now owns 267,941 shares of the company’s stock worth $27,008,000 after purchasing an additional 14,606 shares during the last quarter. Daiwa Securities Group Inc. boosted its position in shares of Cardinal Health by 0.7% during the fourth quarter. Daiwa Securities Group Inc. now owns 27,436 shares of the company’s stock valued at $2,765,000 after purchasing an additional 178 shares in the last quarter. Latitude Advisors LLC boosted its position in shares of Cardinal Health by 6.2% during the fourth quarter. Latitude Advisors LLC now owns 2,512 shares of the company’s stock valued at $253,000 after purchasing an additional 146 shares in the last quarter. Scissortail Wealth Management LLC bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $314,000. Finally, HealthInvest Partners AB bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $4,838,000. Institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CAH. UBS Group lifted their price target on Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. TheStreet cut Cardinal Health from a “b-” rating to a “c+” rating in a research note on Wednesday, December 27th. Argus upgraded Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. Finally, SVB Leerink initiated coverage on Cardinal Health in a research note on Monday, February 26th. They set an “outperform” rating and a $125.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $103.07.

Check Out Our Latest Stock Analysis on CAH

Cardinal Health Stock Up 2.1 %

NYSE CAH opened at $108.19 on Friday. The firm has a market cap of $26.32 billion, a price-to-earnings ratio of 42.59, a price-to-earnings-growth ratio of 1.02 and a beta of 0.68. The business has a 50-day moving average price of $109.59 and a 200-day moving average price of $104.18. Cardinal Health, Inc. has a twelve month low of $77.56 and a twelve month high of $116.04.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The firm had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. During the same quarter in the prior year, the company posted $1.32 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. Research analysts expect that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s payout ratio is presently 78.74%.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.